Cargando…
Resveratrol retards progression of diabetic nephropathy through modulations of oxidative stress, proinflammatory cytokines, and AMP-activated protein kinase
BACKGROUND: Diabetic nephropathy (DN) has been recognized as the leading cause of end-stage renal disease. Resveratrol (RSV), a polyphenolic compound, has been indicated to possess an insulin-like property in diabetes. In the present study, we aimed to investigate the renoprotective effects of RSV a...
Autores principales: | Chang, Chih-Chun, Chang, Chieh-Yu, Wu, Yang-Tzu, Huang, Jiung-Pang, Yen, Tzung-Hai, Hung, Li-Man |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3150248/ https://www.ncbi.nlm.nih.gov/pubmed/21699681 http://dx.doi.org/10.1186/1423-0127-18-47 |
Ejemplares similares
-
Diabetes, Inflammation, Proinflammatory Cytokines, and Diabetic Nephropathy
por: Navarro, Juan F., et al.
Publicado: (2006) -
Downregulation of proinflammatory cytokines in HTLV-1-infected T cells by Resveratrol
por: Fuggetta, Maria Pia, et al.
Publicado: (2016) -
Activation of Estrogen Receptor Is Crucial for Resveratrol-Stimulating Muscular Glucose Uptake via Both Insulin-Dependent and -Independent Pathways
por: Deng, Jen-Ying, et al.
Publicado: (2008) -
AMP-Activated Protein Kinase–Deficient Mice Are Resistant to the Metabolic Effects of Resveratrol
por: Um, Jee-Hyun, et al.
Publicado: (2010) -
Resveratrol Protects Osteoblasts Against Dexamethasone-Induced Cytotoxicity Through Activation of AMP-Activated Protein Kinase
por: Wang, Liang, et al.
Publicado: (2020)